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Type I interferons (IFNs) are important for antiviral and
autoimmune responses. Retinoic acid-induced gene
I (RIG-I) and mitochondrial antiviral signaling (MAVS)
proteins mediate IFN production in response to
cytosolic double-stranded RNA or single-stranded
RNA containing 50-triphosphate (50-ppp). Cytosolic
B form double-stranded DNA, such as poly(dA-
dT)dpoly(dA-dT) [poly(dA-dT)], can also induce IFN-
b, but the underlying mechanism is unknown. Here,
we show that the cytosolic poly(dA-dT) DNA is con-
verted into 50-ppp RNA to induce IFN-b through the
RIG-I pathway. Biochemical purification led to the
identification of DNA-dependent RNA polymerase III
(Pol-III) as the enzyme responsible for synthesizing
50-ppp RNA from the poly(dA-dT) template. Inhibition
of RNA Pol-III prevents IFN-b induction by transfec-
tion of DNA or infection with DNA viruses. Further-
more, Pol-III inhibition abrogates IFN-b induction by
the intracellular bacterium Legionella pneumophila
and promotes the bacterial growth. These results
suggest that RNA Pol-III is a cytosolic DNA sensor
involved in innate immune responses.
INTRODUCTION
Innate immunity is the first line of host defense against microbial
pathogens. Host cells utilize their pattern recognition receptors
(PRRs) to detect pathogen-associated molecular patterns
(PAMPs). The Toll-like receptor family (TLRs) is one class of
PRRs that recognize PAMPs including lipoproteins, lipopolysac-
charides (LPS), double-stranded RNA (dsRNA), single-stranded
RNA (ssRNA), and unmethylated CpG DNA (reviewed by Akira
et al., 2006). Ligand-engaged TLRs recruit the adaptor proteins
MyD88 or TRIF to activate downstream kinases including IkB
kinase complex (IKK) and IKK-related kinases (TBK1 and IKK3),
which activate the transcription factors nuclear factor-kappa B
(NF-kB) and interferon regulatory factors (IRFs), respectively.576 Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc.NF-kB and IRFs function together in the nucleus to induce type
I interferons (IFNs; e.g., IFN-a and IFN-b) and other cytokines.
In another PRR pathway, cytosolic RNAs are recognized by
RIG-I-like receptors (RLRs), which include RIG-I, MDA5, and
LGP2 (Yoneyama et al., 2004). RLRs contain RNA helicase
domains that recognize viral double-stranded RNA. In addition,
RIG-I and LGP2 contain a C-terminal regulatory domain that
recognizes single-stranded RNA containing 50-triphosphate,
which distinguishes foreign (e.g., viral) RNAs from self-RNAs
that normally contain 50 modification (e.g., capped mRNA).
RIG-I and MDA5 also contain N-terminal tandem caspase acti-
vation and recruitment domains (CARD), which interact with
the CARD domain of mitochondrial antiviral signaling protein
(MAVS, also known as IPS-1, VISA, and CARDIF) (Kawai et al.,
2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005).
MAVS localizes on the mitochondrial outer membrane through
its C-terminal transmembrane domain, and this localization is
important for MAVS to activate the cytosolic kinases IKK and
TBK1 to induce IFNs (Seth et al., 2005).
Like RNA, accumulation of foreign or self-DNA in the cytosol
also triggers potent innate immune responses. DNA can be intro-
duced into the cytosol of mammalian cells after infection with
DNA viruses or bacteria, and the detection of cytosolic DNA is
important for mounting an immune response against these path-
ogens. Under certain conditions, self-DNA is inappropriately
delivered to the cytosol, resulting in autoimmune responses.
For example, DNase II-deficient macrophages lack the ability
to digest self-DNA from engulfed apoptotic cells, leading to
IFN-b production (Okabe et al., 2005; Yoshida et al., 2005).
However, the mechanism by which cytosolic DNA induces
IFNs is not well understood. In particular, the sensor that detects
cytosolic DNA and triggers IFN production has remained largely
unknown. Although DNA-dependent activator of IFN-regulatory
factors (DAI) has been proposed to be a potential cytosolic
DNA sensor (Takaoka et al., 2007), DAI-deficient mice still
produce interferons in response to B form DNA and have similar
innate and adaptive immune responses to those of wild-type
mice (Ishii et al., 2008). Recent studies identify AIM2 as a cyto-
solic DNA sensor that activates the inflammasome and cas-
pase-1 (reviewed by Schroder et al., 2009). However, AIM2 is
not involved in type I interferon induction by cytosolic DNA.
Genetic studies have shown that cytosolic DNA can induce
IFN production inmouse cells lacking RIG-I orMAVS, suggesting
that the DNA signaling pathway is distinct from the RIG-I
pathway (Ishii et al., 2006; Sun et al., 2006). Nevertheless, there
is evidence that in certain human cell lines the induction of IFN-b
by transfected double-stranded DNA depends on RIG-I and
MAVS (Cheng et al., 2007; Ishii et al., 2006). However, RIG-I
binds to RNA but not DNA, raising the question of how DNA
might activate the RIG-I pathway.
In this report, we show that the double-stranded DNA (dsDNA)
poly(dA-dT)dpoly(dA-dT), herein referred to as poly(dA-dT), is
converted to an RNA species in the cytosol to trigger the RIG-I
pathway in human and mouse cells. This RNA species contains
50-triphosphate and forms a double-stranded RNA. The conver-
sion of DNA to RNA can be recapitulated in vitro with cytosolic
extracts. Biochemical purification led to the identification of
DNA-dependent RNA polymerase III (Pol-III) as the enzyme
responsible for transcribing the DNA template into an RNA ligand
that activates RIG-I. RNA interference (RNAi)-mediated knock-
down of Pol-III expression or inhibition of its enzymatic activity
impedes interferon induction by transfection of DNA or infection
with several DNA viruses, including adenovirus, herpes simplex
virus 1 (HSV-1), and Epstein-Barr virus (EBV). Moreover, Pol-III
inhibition blocks interferon induction by the intracellular bacte-
rium Legionella pneumophila. These results strongly suggest
that Pol-III is a cytosolic DNA sensor that triggers type I interferon
production through the RIG-I pathway.
RESULTS
Cytosolic DNA Triggers the RIG-I Pathway through
an Intermediary RNA
In the course of attempting to identify a cytosolic DNA sensor
involved in IFN-b production, HEK293 cells were transfected
with various DNA together with a luciferase reporter driven by
the IFN-b promoter. The cell lysates were analyzed by luciferase
activity assays as well as native gel electrophoresis to detect
IRF3 dimerization (Figure 1A). As controls, the cells were also
transfectedwith the synthetic RNA poly(I:C) or infectedwith Sen-
dai virus (SeV), an RNA virus known to induce IFN-b. Among the
DNA tested, including poly(dA-dT), poly(dI-dC)ddpoly(dI-dC)
[poly(dI-dC)], calf thymus DNA, PCR fragments of different
lengths, and a linearized plasmid (pcDNA3), only poly(dA-dT)
could activate IRF3 and induce IFN-b. Silencing the expression
of RIG-I or MAVS with two different pairs of small interfering
RNA (siRNA) oligos strongly inhibited IRF3 and IFN-b induction
by poly(dA-dT) (Figure 1B). Pretreatment of poly(dA-dT) with
DNase-I completely abrogated its ability to induce IFN-b,
whereas RNase A treatment had no effect (Figure 1C), indicating
that RIG-I-dependent induction of IFN-b was not due to some
RNA contaminants in poly(dA-dT). Synthetic DNA oligos contain-
ing 50 or 100 nucleotides of AT sequencewere potent inducers of
IFN-b, whereas GCAT or GC sequences of comparable lengths
had little activity (Figure S1 available online). Interestingly, inser-
tion of 10 GC nucleotides in themiddle of AT50 abolished its IFN-
b-inducing activity. Poly-T, poly-A, or the duplex DNA formed
between poly-T and poly-A did not induce IFN-b. A duplex DNA
containing 80% AT sequence was capable of inducing IFN-b,whereas a DNA containing 50% AT sequence was inactive
(Figure S1). Taken together, these results suggest that IFN
induction by DNA in HEK293 cells requires AT-rich sequence
and certain length (30–50 nucleotides, see below). Poly(dA-dT),
but not other DNA tested, also activated IRF3 and induced
IFN-b in HeLa cells; the IRF3 activation was inhibited by RNAi
of RIG-I or MAVS (Figure S2), indicating that RIG-I-dependent
induction of IFN-b by poly(dA-dT) is not restricted to HEK293
cells.
To identify the ligands responsible for RIG-I activation in cells
transfected with poly(dA-dT), we extracted nucleic acids from
the cell lysates with phenol and chloroform and tested the ability
of these nucleic acids to induce IFN-b. The nucleic acids
extracted from cells transfected with poly(dA-dT) potently
induced IFN-b. Surprisingly, the activity of nucleic acids
extracted from poly(dA-dT)-transfected cells was sensitive to
RNase A, but not DNase I, suggesting that some intermediary
RNAs capable of inducing IFN-b were activated or produced
after poly(dA-dT) transfection (Figure 1D).
To test whether the production of IFN-inducing RNA depends
on the lengthand/or compositionofcytosolicDNA,we transfected
synthetic DNA oligos, as well as longer poly(dA-dT) and poly(dG-
dC) (purchased from GE Healthcare), into HEK293-IFNb-Luc
reporter cells to measure IFN-b induction by the DNA. RNA from
the transfected cells was extracted, then transfected into the
same IFN-b reporter cells to measure IFN-b induction by the
RNA (Figure 1E). Interestingly, poly(dA-dT) containing as few as
30 base pairs was capable of directing the production of IFN-
inducing RNA in the transfected cells. By contrast, even long
poly(dG-dC) and GCAT DNA sequences were unable to produce
any IFN-inducing RNA.
Previous studies showed that mouse embryonic fibroblasts
(MEFs) lacking RIG-I or MAVS were still capable of producing
IFN-b after transfection of DNA, including poly(dA-dT) (Ishii
et al., 2006; Sun et al., 2006). To determine whether the trans-
fection of DNA in MEF cells also leads to the generation of
IFN-inducing RNA, we transfected MAVS-deficient primary
MEF cells with various DNA and then measured IFN-b produc-
tion by ELISA. Indeed, poly(dA-dT), poly(dI-dC), and calf thymus
DNA, but not Sendai virus infection, induced IFN-b production in
MAVS-deficient MEF cells (Figure 1F). When RNA extracted
from these cells was transfected into HEK293-IFNb-Luc
reporter cells, only the RNA extracted from poly(dA-dT)-trans-
fected and Sendai virus-infected cells was capable of inducing
IFN-b (Figure 1G). These results suggest that MEF cells possess
two cytosolic DNA-sensing pathways, one detecting DNA irre-
spective of sequence composition and inducing IFN-b through
a MAVS-independent mechanism, and the other recognizing
the poly(dA-dT) sequence and producing RNA ligands that
trigger the RIG-I-MAVS pathway. Both poly(dA-dT) and
poly(dG-dC) DNA induced IFN-b in bone marrow-derived
macrophages (BMDMs), but only RNAs extracted from pol-
y(dA-dT)-transfected BMDMs were capable of inducing IFN-b
when they were transfected into the HEK293-IFNb-Luc reporter
cells (Figures 1H and 1I). Therefore, poly(dA-dT) leads to the
generation of IFN-inducing RNA not only in transformed cells
(HEK293 and HeLa), but also in primary fibroblasts (MEFs)
and macrophages.Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc. 577
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Identification of the Intermediary RNA as Double-
Stranded RNA Containing 50-Triphosphate
RIG-I recognizes dsRNA and ssRNA bearing 50-triphosphate
(Hornung et al., 2006; Pichlmair et al., 2006). To determine
the features of the IFN-inducing RNA generated in cells trans-
fected with poly(dA-dT), we treated the RNA isolated from
HEK293 cells with shrimp alkaline phosphatase (SAP) or poly-
nucleotide kinase (PNK) and then tested its ability to induce
IFN-b (Figure 2A). The activity of the RNA was destroyed by
SAP, but not PNK treatment. Using PNK to add one phosphate
to the SAP-treated RNA did not restore the activity, indicating
that RNA containing 50-monophosphate fails to induce IFN-b.
Treatment of the RNA extracted from poly(dA-dT)-transfected
cells with terminator exonuclease (Ter Ex), an enzyme that
specifically digests RNA containing 50-monophosphate, did
not impair the IFN-inducing activity of the RNA (Figure 2B, lower
panel), whereas treatment with RNase If (an RNase sensitive to
heat inactivation) destroyed IFN-b induction. Control experi-
ments showed that Ter Ex efficiently degraded 50-monophos-
phate (50-p) RNA generated by the treatment of RNA with
SAP followed by PNK (Figure 2B; upper panel). These results
show that the IFN-inducing RNA contained more than one
phosphate at the 50 end, most likely 50-triphosphate (see the
Discussion).
Next, to determine the structure of the intermediary RNA, we
treated the RNA with RNases known to be specific for ssRNA
or dsRNA. The specificity of the RNases was tested with
in vitro-synthesized ssRNA or dsRNA (Figure 2C, upper panel).
RNase III specifically digests dsRNA, but not ssRNA, whereas
RNase T1 has the opposite specificity. ssRNA was more sensi-
tive to digestion by low concentration of RNase A than was
dsRNA. When the RNA from poly(dA-dT)-transfected cells was
treated with RNase III and a high concentration of RNase A
that degrades dsRNA, it lost its ability to induce IFN-b. By
contrast, RNase T1 or a low concentration of RNase A, which
degrades ssRNA, had no effect on the ability of the RNA to
induce IFN-b (Figure 2C, lower panel). These results suggest
that the IFN-inducing RNA from poly(dA-dT)-transfected cells
is double-stranded RNA containing 50-triphosphate. To deter-
mine whether the RNA is a RIG-I ligand, we immunoprecipitatedRIG-I from HEK293 cells stably expressing FLAG-tagged RIG-I
using a FLAG-specific antibody (M2). The RNA in the immuno-
precipitates was extracted and tested for IFN-b induction
(Figure 2D). The RNA extracted from the RIG-I complex immuno-
precipitated from poly(dA-dT)-transfected cells induced IFN-b,
whereas the RIG-I complex from mock-transfected cells did
not contain IFN-inducing RNA. Taken together, these results
indicate that poly(dA-dT) instructs or stimulates the production
of dsRNA containing 50-triphosphate, which binds to and acti-
vates RIG-I.
There are at least two potential mechanisms bywhich poly(dA-
dT) leads to the generation of IFN-inducing RNA. Poly(dA-dT)
might activate certain enzymes such as RNA kinases, which
modify endogenous RNAs and convert them into RIG-I ligands.
Alternatively, poly(dA-dT) might serve as a template to direct
the de novo synthesis of RNA by some enzymes, such as a
DNA-dependent RNA polymerase. To determine whether RNA
polymerase II (RNA Pol-II) is involved in the synthesis of the
IFN-inducing RNA, we transfected poly(dA-dT) into HEK293 cells
that were pretreated with the RNA Pol-II inhibitor a-amanitin, and
then total RNA was extracted from the cells and transfected into
the IFN-b reporter cell line. a-amanitin blocked the transcription
of IFN-b induced by poly(dA-dT) (Figure S3A), but did not inhibit
the generation of the RNA, which, when extracted from the drug-
treated cells and retransfected into HEK293-IFN-b reporter cells,
was still capable of inducing IFN-b (Figure S3B). These results
indicate that RNA polymerase II is not involved in transcribing
the intermediary RNA from poly(dA-dT). Actinomycin D, which
intercalates GC-rich double-stranded DNA and blocks transcrip-
tional elongation, also did not prevent the generation of IFN-
inducing RNA in poly(dA-dT)-transfected cells (Figure S3B), sug-
gesting that either actinomycin D did not inhibit transcription
from poly(dA-dT) or the RNA was not generated through de
novo synthesis.
A Cell-free System that Generates IFN-Inducing RNA
To dissect the mechanism by which poly(dA-dT) leads to the
production of IFN-inducing RNA, we tested whether the DNA
can trigger the RNA generation in a cell-free system. HeLa
cytosolic extracts (S100) were incubated with poly(dA-dT),Figure 1. Poly(dA-dT) Activates RIG-I-Dependent IFN-b Production through Intermediary RNA
(A) HEK293 cells were transfected for 16 hr with the reporter plasmid IFN-b-Luc (25 ng/ml), pCMV-LacZ (50 ng/ml), and various types of DNA or RNA [poly(I:C)] as
indicated (1 mg/ml) before cell lysates were prepared for luciferase reporter assay (upper panel) or IRF3 dimerization assay (lower panel). PCR, linear PCR frag-
ments of the indicated size; HindIII, HindIII-linearized fragment of pcDNA3; marker, DNA marker (0.1-10 kB; NEB); SeV, Sendai virus infection.
(B) HEK293 cells were transfected with control siRNA oligos against GFP, two different pairs of siRNA oligos (a and b) against RIG-I, or MAVS. Subsequently, cells
were cotransfected with IFN-b-Luc and pCMV-LacZ. After 24 hr, cells were transfected with poly(dA-dT) or infected with SeV before functional assays were per-
formed as described in (A).
(C) HEK293 cells were transfected with poly(dA-dT) that had been predigested with DNase I or RNaseA, and then IFN-b luciferase reporter assay was carried out
as described in (A).
(D) HEK293 cells were transfected with or without poly(dA-dT) for 16 hr, and then nucleic acids were prepared, digested with DNase I or RNase A, and transfected
into HEK293-IFNb-luciferase reporter cells to measure IFN-b induction.
(E) HEK293 cells were transfected with DNA of different sizes and compositions as indicated. Total RNAwas extracted, then transfected into HEK293-IFNb-lucif-
erase reporter cells. In parallel experiments, the DNA was directly transfected into the reporter cells.
(F) MAVS-deficient MEF cells were transfected with various DNA or infected with SeV, and then IFN-b in the culture supernatants was measured by ELISA.
(G) MAVS-deficient MEF cells were treated as described in (F), and then total RNAs were extracted and transfected into HEK293-IFNb-luciferase reporter cells.
(H) Mouse BMDM were transfected with poly(dA-dT) or poly(dG-dC) for 8 hr before total RNAs were extracted for qPCR. The expression level of the IFN-b gene
was normalized with that of the b-actin gene.
(I) BMDM cells were transfected as described in (H), and then total RNAs were extracted and transfected into HEK293-IFNb-luciferase reporter cells.
Error bars represent the variation range of duplicate experiments (A–G and I) or standard deviation of triplicate (H) experiments.Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc. 579
Figure 2. Properties of the IFN-Inducing RNA Derived from Poly(dA-dT)
(A) RNAs extracted from poly(dA-dT)- or mock-transfected cells were treated with shrimp alkaline phosphatases (SAP), polynucleotide kinase (PNK), or SAP fol-
lowed by PNK at 37C for 1 hr. The RNAs were then transfected into HEK293-IFNb-luciferase reporter cells.
(B) Upper panel: poly(A-U) RNA transcribed by T7 polymerase was treated with terminator exonuclease (Ter Ex), PNK, or SAP at 37C for 1 hr. Two aliquots of
SAP-treated RNA were phosphorylated with PNK before one of the aliquots was further treated with Ter Ex. Lower panel: RNAs extracted from poly(dA-dT)- or
mock-transfected cells were treated with RNase-If or Ter Ex and then transfected into HEK293-IFNb-luciferase reporter cells.
(C) Upper panels: single-stranded RNA (ssRNA) or double-strand RNA (dsRNA) generated by T7 polymerase was digested with various amounts of the indicated
RNase, separated on agarose gel, and then visualized by ethidium bromide staining. Lower panel: RNAs extracted from poly(dA-dT)-transfected cells were
digested with the indicated RNase, then transfected into HEK293-IFNb-luciferase reporter cells.
(D) Poly(dA-dT) was transfected into HEK293 cells stably expressing FLAG-tagged RIG-I, which was subsequently immunoprecipitated with an anti-FLAG anti-
body (M2) or control IgG. Nucleic acids in the cell extracts (S100), unbound supernatant (sup), and immunoprecipitates (beads) were extracted and then trans-
fected into HEK293-IFNb-luciferase reporter cells (upper panel). An aliquot of S100, sup, and beads was separated by SDS-PAGE and immunoblotted with
a FLAG antibody (lower panel).
Error bars represent the variation range of duplicate experiments.ATP, MgCl2, and RNase inhibitors at 30
C for 1 hr, followed by
phenol/chloroform extraction and DNase I treatment. The RNA
was then tested for IFN-b induction. Remarkably, the RNA580 Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc.generated in this cell-free system potently activated the IFN-b
promoter (Figure 3A). This activity was abolished by RNase
but not DNase treatment, indicating that the IFN-inducing
Figure 3. In Vitro Generation of IFN-Inducing RNA Requires ATP and UTP
(A) HeLa S100 was incubated with poly(dA-dT) or poly(dG-dC) and ATP. After DNase I and/or RNase A treatment, RNA was extracted and transfected into
HEK293-IFNb-luciferase reporter cells.
(B) HeLa S100 was precipitated with 40% ammonium sulfate, and then the supernatant was further precipitated with 80% ammonium sulfate. The precipitates
were dialyzed and incubated with poly(dA-dT) and ATP in the presence or absence of the supernatant from heat-treated HeLa S100 (‘‘heat sup’’). RNA from the
in vitro reaction was extracted and transfected into HEK293-IFNb-luciferase reporter cells.
(C) Scheme of purification of heat-resistant factor required for the generation of IFN-inducing RNA.
(D) Chromatogram (A260) of the small molecules on Superdex peptide column (last step; lower panel). Fractions from the Superdex peptide column were incu-
bated with a protein fraction from 40% ammonium sulfate precipitation, poly(dA-dT), and ATP, and then RNA from the reaction was extracted for IFN-b reporter
assays (upper panel).
(E) NMR spectra of fractions 18 (F18; top spectrum) and 21 (F21; bottom). The middle spectrum is a mixture of authentic UDP and UTP standards (1:2.5).
(F) UTP, CTP, GTP, or UTP/CTP/GTP (1.5mM) was used to substitute for the ‘‘heat sup’’ in the in vitro reaction, then RNAwas extracted for IFN-b reporter assays.
(G) Reactions containing a crude protein fraction (40% ammonium sulfate precipitate), poly(dA-dT), ATP, and UTP (complete reaction) or lacking one of the
components were carried out in vitro, and then RNA was extracted for IFN-b reporter assays.
Error bars represent the variation range of duplicate experiments.activity was not due to contaminating poly(dA-dT) (Figure 3A).
Similar to the cell-based assays, poly(dG-dC), poly(dI-dC), or
calf thymus DNA was incapable of triggering the production
of IFN-inducing RNA in the in vitro system (Figure S4A). The
cell lysates from human (HEK293 and THP1) and mouse
(MEF and Raw264.7) cell lines were also capable of gener-
ating IFN-inducing RNA in the presence of poly(dA-dT)
(Figure S4B). Furthermore, the RNA generated in vitro lostits ability to induce IFN-b after treatment with SAP or the
enzymes that digest dsRNA (RNase III and high concentration
of RNase A), but not those that digest ssRNA (RNase T1
and RNase A at low concentration) (Figures S4C and S4D).
The in vitro-generated IFN-inducing RNA was also resistant
to terminator exonuclease, indicating that it does not contain
50-monophosphate (Figure S4E). These results indicate that
the cell-free system that we established faithfully recapitulatesCell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc. 581
the generation of IFN-inducing RNA in poly(dA-dT)-transfected
cells.
ATP and UTP Are Required for the Generation
of IFN-Inducing RNA In Vitro
To identify the factors required for the generation of IFN-inducing
RNA, we first divided HeLa cytosolic extracts (S100) into two
parts by 40% and 40%–80% ammonium sulfate precipitation.
The precipitates were dialyzed (5 kDa cutoff) and then assayed
for their ability to generate IFN-inducing RNA in the presence
of poly(dA-dT) and ATP. Surprisingly, the 40% and 40%–80%
fractions did not have the activity either alone or in combination
(Figure 3B), suggesting that some factors were lost during dial-
ysis or were not precipitated by 80% ammonium sulfate. To
test whether HeLa S100 contains some small molecules or
other heat-resistant factors required for the production of IFN-
inducing RNA, we treated HeLa S100 at 75C for 15 min to
precipitate most proteins, and the supernatant (‘‘heat sup’’)
was tested for its ability to support the generation of IFN-
inducing RNA in the presence of the dialyzed fractions from
ammonium sulfate precipitation. Addition of the ‘‘heat sup’’ to
the reaction containing 40% ammonium sulfate-precipitated
proteins led to a robust production of IFN-inducing RNA (Fig-
ure 3B). The activity in the ‘‘heat sup’’ was resistant to proteinase
K, DNase I, and RNase If (Figure S5A) and could penetrate
through a filter with 5 kDa molecular weight cutoff (data not
shown), suggesting that some small molecules were required
for generating IFN-inducing RNA. We purified the small mole-
cules through the purification scheme indicated in Figure 3C
and found two distinct peaks of activity in the last step of purifi-
cation using a gel filtration column (Superdex peptide; Figure 3D).
The fractions from both peaks had maximum absorption at 254
nanometer (data not shown), suggesting that they might be
nucleotides or derivatives of nucleotides.
Two active fractions (18 and 21) from the Superdex peptide
column were further analyzed by LC-MS (Figure S6) and NMR
(Figure 3E). LC-MS analysis (see the Supplemental Data for
details) of fraction 21 (F21) indicated the presence of UDP with
anm/z of 403.0 [M–H]+, although the signal was partially masked
by the presence of HEPES buffer (Figure S6). The 1H NMR spec-
trum of F21 measured in D2O at 600 MHz showed the character-
istic signals of a uridine nucleotide: two aromatic doublets at
d 7.89 and 5.91 ppm, an anomeric doublet at 5.87 ppm, and
overlapping multiplets of the ribose (Figure 3E). Comparison to
an authentic standard of UDP in D2O with 10 mM HEPES and
40 mMKCl showed an excellent overlap in the 1HNMR spectrum,
unequivocally establishing the active component of F21 as UDP.
The second active fraction, F18, was determined to be a 2:1
ratio of UTP to UDP. LC-MS clearly showed the presence of
UDP, but under the initial conditions we were unable to detect
UTP. 1H NMR analysis showed two doublets at d 7.85 and
7.89 ppm in a 2:1 ratio and a complex mixture of signals from
d 5.85 to 5.90 ppm (Figure 3E). The close similarity of the two
sets of signals between F18 and F21 indicated the presence of
a metabolite related to UDP, most likely UTP. 1H NMR of an
authentic standard of 1:2.5 UDP:UTP with 10 mM HEPES and
40 mM KCl was nearly identical to F18. The small difference in
chemical shift can be attributed to a difference in pH and ionic582 Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc.strength between F21 and the authentic standard. We originally
missed the presence of UTP in F18 by LC-MS using our original
LC conditions (condition 1 in experimental procedures), but
changing the buffer to 0.1 M NH4OAc as a buffer (condition 2)
allowed us to clearly verify the presence of UTP with an m/z of
483.0 [M–H]+ (Figure S6).
To verify the requirement of UTP and UDP in the production of
IFN-inducing RNA, we replaced the ‘‘heat sup’’ with UTP, CTP,
GTP, or a mixture of these three nucleotides in the in vitro assay
containing the dialyzed protein (40% ammonium sulfate precip-
itate), poly(dA-dT), and ATP. Only UTP could support the gener-
ation of IFN-inducing RNA (Figure 3F). UDP, UMP, and uridine,
but not dNTP, also supported IFN induction in the in vitro assays
(Figures S5B andS5C), suggesting that the protein fractionmight
have nucleotide kinase activity to convert UDP, UMP, or uridine
to UTP. As the reaction mixtures always contained ATP, we
removed ATP from the reaction and found that this removal abol-
ished the production of IFN-inducing RNA (Figure 3G). Therefore,
both ATP and UTP are required for the generation of IFN-
inducing RNA in the in vitro system.
DNA-Dependent RNA Polymerase III Catalyzes
the Generation of IFN-Inducing RNA
Treatment of HeLa S100with proteinase K completely destroyed
the generation of IFN-inducing RNA in the in vitro system, indi-
cating that one or more proteins in S100 are required for the
RNA generation (Figure 4A). We purified the active proteins
fromHeLa S100 through eight steps of conventional chromatog-
raphy (Figure 4B, left). Fractions from the last Superdex-200 step
were analyzed for their ability to stimulate the generation of IFN-
inducing RNA in the presence of poly(dA-dT), ATP, and UTP (Fig-
ure 4B, upper right). Aliquots of the fractions were also analyzed
by silver staining (Figure 4B, lower right). At least eight visible
bands copurified with the activity. Three of these bands, p45,
p40, and p23, were identified by nanoelectrospray tandemmass
spectrometry. The p45 bands contained subunit D of DNA-
directed RNA polymerase III (POLR3D), p40 contained POLR3F,
POLR3C, POLR3D, and POLR3H, and p23 contained POLR3H,
POLR3G, and POLR3D. Immunoblotting showed that POLR3F
and POLR3G copurified with the activity that generates IFN-
inducing RNA (Figure S7). As these proteins are subunits of
RNA polymerase III, we attempted to identify all the subunits of
the Pol-III complex. We established a HEK293 cell line stably
expressing FLAG-POLR3F and immunoprecipitated the Pol-III
complex with the FLAG antibody. The Pol-III complex was eluted
with a FLAG peptide and then immunoprecipitated again with an
antibody against POLR3G or a control IgG (Figure 4C). Silver
staining of the immunoprecipitated proteins revealed at least 12
distinct bands that were present in the POLR3G complex, but
not in the control IgG sample. Nanoelectrospraymass spectrom-
etry of these unique bands identified 11 known Pol-III subunits
(POLR3A, POLR3B, POLR3C, POLR3D, POLR3E, POLR3F,
POLR3G, POLR3GL, POLR3H, POLR1C, and CGRP-RCP) (Hu
et al., 2002) and two other proteins (TRM1-like and RPS4) whose
roles in Pol-III-mediated transcription have not been reported
(Table S1). Importantly, the purified Pol-III complex immunopre-
cipitated with anti-POLR3G, but not the control IgG
Figure 4. Purification and Identification of Pol-III
(A) HeLa S100 was incubated with or without proteinase K and then incubated with poly(dA-dT) and ATP before RNA was extracted for IFN-b reporter assays.
(B) Protein purification was carried out according to the scheme shown on the left, and fractions from the last Superdex-200 column were analyzed for their
activity to produce IFN-inducing RNA (upper panel) and by silver staining (lower panel). Arrows indicate the proteins copurifying with the activity and analyzed
by mass spectrometry. The asterisk indicates chicken albumin, which was added as a carrier protein during purification.
(C) Cytosolic extracts from HEK293 cells stably expressing FLAG-POLR3F were used for tandem affinity purification of the Pol-III complex, first with anti-FLAG
agarose (M2) and then with an antibody against POLR3G or control IgG. The precipitated proteins were analyzed by silver staining. Unique bands from anti-
POLR3G were identified by mass spectrometry.
(D) The immunopurified Pol-III complex from (C) was incubated with poly(dA-dT), ATP, and UTP before RNAwas extracted for IFN-b reporter assays. SM, starting
material (for IP).
(E) HeLa S100 was immunoprecipitated twice (IP1 and IP2) with an antibody specific for TBP, POLR3F, POLR3G, or control IgG. The precipitated proteins were
tested for their activity to produce IFN-inducing RNA (upper panel) and analyzed by immunoblotting.
Error bars represent the variation range of duplicate experiments.Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc. 583
immunoprecipitate, was sufficient to catalyze the synthesis of
IFN-inducing RNA in the presence of poly(dA-dT), ATP and UTP
(Figure 4D).
To determine whether endogenous Pol-III could catalyze the
synthesis of IFN-inducing RNA from poly(dA-dT), we purified
the Pol-III complex from HeLa S100 by immunoprecipitation.
Proteins immunoprecipitated with the antibodies against
POLR3F or POLR3G, but not control IgG, had the ability to
generate IFN-inducing RNA (Figure 4E). We also tested the
involvement of TATA-binding protein (TBP), which is known to
recognize the dT-dA sequence present in most Pol-II and
some Pol-III promoters. Proteins precipitated with an antibody
against TBP did not contain POLR3F or POLR3G, nor did they
catalyze the synthesis of IFN-inducing RNA. Taken together,
these results show that the core RNA Pol-III complex catalyzes
the generation of IFN-inducing RNA from poly(dA-dT) in vitro.
Pol-III Catalyzes the Synthesis of Poly(A-U) RNA
Using Poly(dA-dT) as a Template
Poly(dA-dT), but not poly(dG-dC), leads to the generation of IFN-
inducing RNA in transfected cells (Figure 1E) and crude cell
lysates (Figure S4A). Similarly, the Pol-III complex purified from
HEK293 stable cells expressing FLAG-tagged POLR3D or
POLR3F catalyzed the synthesis of IFN-inducing RNA from
poly(dA-dT), but not poly(dG-dC) (Figure 5A). Ethidium bromide
staining showed that poly(dA-dT), but not poly(dG-dC), served
as the template for RNA synthesis in vitro (Figure 5B). In vitro
transcription experiments showed that Pol-III catalyzed the
incorporation of a-32P-UTP into RNA when poly(dA-dT), but
not calf thymus DNA, was used as the template (Figure 5C).
Northern blot analysis with a radiolabeled poly(A-U) RNA probe
confirmed that the RNA synthesized by Pol-III in the presence
of poly(dA-dT) was indeed poly(A-U) (Figure 5D, lane 2).
To test whether poly(dA-dT) directs the synthesis of poly(A-U)
RNA in cells, we transfected poly(dA-dT) into HEK293 cells
stably expressing FLAG-tagged RIG-I, immunoprecipitated
RIG-I with the FLAG antibody, and then analyzed the RIG-I
bound RNA by northern blotting using the radiolabeled poly-
(A-U) RNA probe (Figure 5D; lanes 4–9). Poly(A-U) RNA was
present in the RIG-I complex isolated from poly(dA-dT)-trans-
fected cells but not mock-transfected or Sendai virus-infected
cells. These results strongly suggest that poly(dA-dT) serves as
a template to direct the synthesis of poly(A-U) RNA by Pol-III.
Due to its sequence complementarity, poly(A-U) probably
forms a double-stranded RNA, and it apparently retains the
50-triphosphate, rendering it a strong RIG-I ligand.
Pol-III Is Necessary for the Generation of IFN-Inducing
RNA
To determine whether Pol-III is the major enzyme responsible
for poly(dA-dT)-dependent RNA synthesis in HeLa S100, we
depleted Pol-III from the extract by repeated immunoprecipita-
tion with an antibody against POLR3F. The Pol-III depleted
S100 was largely devoid of the activity to synthesize IFN-
inducing RNA, whereas mock depletion with a control IgG did
not remove the activity (Figure 6A). Consistent with the notion
that the cytoplasmic Pol-III generates IFN-inducing RNA in the
cytosol, RNA isolated from the cytosol of poly(dA-dT)-trans-584 Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc.fected cells strongly induced IFN-b, whereas nuclear RNA iso-
lated from the same cells did not (Figure 6B).
To test whether Pol-III is required for the production of IFN-
inducing RNA in poly(dA-dT)-transfected cells, we took two
independent approaches. In the first approach, we used two
different pairs of siRNA oligos against POLR3F to silence the
expression of this essential Pol-III subunit in HEK293 cells,
then transfected the cells with poly(dA-dT) or infected the cells
with Sendai virus. RNA from these cells was extracted and
then transfected into the HEK293-IFNb-luciferase reporter
cell line. Both siRNA oligos, but not the control GFP siRNA,
strongly inhibited the generation of IFN-inducing RNA in pol-
y(dA-dT)-transfected cells (Figure 6C). In contrast, the produc-
tion of Sendai virus RNA, which is largely carried out by the
viral RNA-dependent RNA polymerase, was not affected by
the knockdown of POLR3F. Northern blot analysis showed
that RNAi of POLR3F blocked the production of RIG-I-associ-
ated poly(A-U) RNA, demonstrating that Pol-III is required for
the transcription of poly(dA-dT) in cells (Figure 6D). In the
second approach, we treated HEK293 cells with a specific
chemical inhibitor of RNA Pol-III, ML-60218 (Wu et al., 2003),
before transfection with poly(dA-dT) or infection with Sendai
virus. This inhibitor selectively inhibited the production of
IFN-inducing RNA in cells transfected with poly(dA-dT) but
not in cells infected with Sendai virus (Figures 6E and 6F).
The partial blockade of IFN-b induction might be due to incom-
plete knockdown and partial chemical inhibition of Pol-III in
cells. Nevertheless, it is clear from these results that Pol-III is
required for the transcription of poly(dA-dT) into poly(A-U)
RNA, which induces IFN-b.
Pol-III Is Required for IFN-b Induction by Legionella
pneumophila
A previous study showed that RNAi of MAVS inhibits IFN-b
induction in a human lung epithelial cell line by Legionella pneu-
mophila (Opitz et al., 2006), a gram-negative intracellular bacte-
rium that infects macrophages and causes Legionnaires’
disease. However, the role of MAVS in immune defense against
Legionella and the underlying mechanism are largely unknown.
We infected BMDM isolated from wild-type and Mavs/ mice
with L. pneumophila and then measured IFN-b expression by
quantitative PCR (qPCR; Figure 7A). The induction of IFN-b by
the bacteria was markedly reduced in Mavs/ macrophages.
Strikingly, the Pol-III inhibitor ML-60218 strongly inhibited
IFN-b induction by L. pneumophila in a dose-dependent manner
(Figure 7B). When the RNA was extracted from the drug-treated
and bacteria-infected cells and then transfected into Raw264.7
macrophages again, IFN-b induction by RNA extracted from
Pol-III inhibited cells was reduced to a level similar to that
observed with RNA from mock-infected cells (Figure 7C), indi-
cating that Pol-III is required for the generation of IFN-inducing
RNA by Legionella. The RNA isolated from the cytoplasm of
Legionella-infected cells contained IFN-inducing activity,
whereas the nuclear RNA from the same cells did not induce
IFN (Figure 7D). Importantly, ML-60218 treatment significantly
increased the bacterial load in themacrophages (Figure 7E), indi-
cating that inhibition of the host Pol-III promotes rather than
impedes bacterial growth. IFN-b treatment restored inhibition
Figure 5. Pol-III Catalyzes the Synthesis of Poly(A-U) RNA Using Poly(dA-dT) as the Template
(A) Pol-III complex was immunopurified from HEK293 cells stably expressing FLAG-tagged POLR3D or POLR3F and then incubated with poly(dA-dT) or poly(dG-
dC) in the presence of NTP. RNA was extracted from the reactions for IFN-b reporter assays. Error bars represent the variation range of duplicate experiments.
(B) RNAs synthesized by in vitro transcription of poly(dA-dT) or poly(dG-dC) were separated by agarose gel eletrophoresis followed by ethidium bromide staining.
(C) RNAs synthesized by in vitro transcription of poly(dA-dT) or calf thymus DNA in the presence of a-32P-UTP and NTP were analyzed by agarose gel electro-
phoresis followed by autoradiography.
(D) HEK293 cells stably expressing FLAG-tagged RIG-I were transfected with poly(dA-dT) (lanes 6 and 7), infected with Sendai virus (lanes 8 and 9), or mock
treated (lanes 4 and 5). RIG-I was subsequently immunoprecipitated with the FLAG antibody (M2) or control IgG, and RNA in the precipitates was extracted
and analyzed by northern blotting with 32P-labeled poly(A-U) RNA used as a probe. In lanes 1–3, RNAs synthesized by in vitro transcription of poly(dA-dT) or
poly(dG-dC) or in the absence of DNA were analyzed by northern blotting. Bottom panel: Immunoprecipitated proteins were analyzed by immunoblotting
with a FLAG antibody. SM, starting material (cell lysates); s, supernatant; b, bound proteins on the beads.of Legionella replication in cells treated with the Pol-III inhibitor
(Figure 7F), demonstrating that Pol-III-induced IFN-b production
is important for suppressing the bacterial replication. Takentogether, these results strongly suggest that Pol-III and MAVS
mediate interferon induction and immune defense against
Legionella.Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc. 585
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Pol-III Mediates IFN-b Induction by DNA Viruses
Some DNA viruses, including adenovirus, HSV-1 and EBV,
induce IFN-b production in a RIG-I dependent matter (Cheng
et al., 2007; Rasmussen et al., 2007; Samanta et al., 2006). To
determine whether Pol-III plays a role in IFN induction by DNA
viruses, we treated Raw264.7 cells with ML-60218 and then in-
fected the cells with adenovirus, HSV-1, or Sendai virus (RNA
virus as a control). IFN-b induction by adenovirus (Figure 7G)
and HSV-1 (Figure 7H) was markedly reduced by ML-60218
treatment. By contrast, ML-60218 treatment had no effect on
IFN-b induction by Sendai virus (Figure 7I), suggesting that the
effect of ML-60218 was not due to general inhibition of IFN-b
synthesis. ML-60218 also inhibited the production of IFN-
inducing RNA in macrophages infected with HSV-1 but not Sen-
dai virus (Figures S8A and S8B).
IFN induction by EBV has been linked to human autoimmune
diseases, including systemic lupus erythematosus (SLE) (Ronn-
blom and Pascual, 2008). Interestingly, EBV-encoded small RNA
1 and 2 (EBER1 and EBER2) are noncoding, nonpolyadenylated
RNAs that form dsRNA-like stem-loop structures (Lerner et al.,
1981). These abundant small RNAs, which contain 50-triphos-
phate, are present in RNP particles that can be precipitated
with anti-La antibody from the SLE patients. We tested the
effects of the Pol-III inhibitor on IFN-b production in an EBV-
producing human B cell line, B95-8. These cells were treated
with different amounts of ML-60218 before total RNA was
extracted for qPCR. The levels of EBER1, EBER2, and IFN-b
RNA were reduced by the treatment with ML-60218 (Figure 7J).
By contrast, the expression of a Pol-II dependent gene, a-actin,
was not affected by the Pol-III inhibitor. ML-60218 also inhibited
the production of IFN-inducing RNA in EBV-infected cells
(Figure S8C). Collectively, these results suggest that Pol-III medi-
ates IFN-b induction in EBV-infected B cells, possibly through
transcription of EBV-encoded small RNAs.
DISCUSSION
In this report, we delineate a mechanism by which AT-rich cyto-
solic DNA induces IFN-b production in human and mouse cell
lines. We found that poly(dA-dT) serves as a template for the
de novo synthesis of poly(A-U) RNA by DNA-dependent RNA
polymerase III. The IFN-inducing activity of the RNA is resistantto terminal exonuclease and RNase T1 but sensitive to alkaline
phosphatase and RNase III, indicating that this is a double-
stranded RNA containing more than one phosphate at the 50
ends. Although at present we cannot definitively determine
whether the RNA contains 50-triphosphate or 50-diphosphate,
Pol-III is known to synthesize RNA containing 50-triphosphate.
Our results that Pol-III is responsible for the synthesis of the
RNA from poly(dA-dT) (Figures 4 and 6), which binds directly to
RIG-I (Figures 2D and 5D), strongly suggest that the RNA
contains 50-triphosphate.
The RNA Pol-III complex is both necessary and sufficient to
catalyze the synthesis of poly(A-U) from poly(dA-dT) in vitro. By
employing RNAi and a specific inhibitor of Pol-III, we show that
Pol-III is required for the production of IFN-inducing RNA by
poly(dA-dT) in cells. Furthermore, Pol-III inhibition significantly
reduced the induction of IFN-b by intracellular bacteria (Legion-
ella pneumophila) and DNA viruses (adenovirus, HSV-1, and
EBV), but not RNA viruses (Sendai virus). Pol-III inhibition also
led to a significant increase of bacterial replication (Legionella
pneumophila). These results strongly suggest that Pol-III plays
a key role in sensing and limiting infection by intracellular
bacteria and DNA viruses.
Cytosolic RNA Pol-III Is a DNA Sensor that Triggers
Innate Immune Response
Pol-III was purified from cytosolic extracts (Figure 4), consistent
with its role as a cytosolic DNA sensor. Cytosolic RNA isolated
from cells transfected with poly(dA-dT) or infected with Legion-
ella strongly induced IFN-b, whereas RNA isolated from the
nucleus of the same cells did not (Figures 6B and 7D), further
supporting our model that cytosolic Pol-III is responsible for
production of IFN-inducing RNA, which is then recognized by
RIG-I in the cytosol. Previous studies utilizing in vitro transcrip-
tion assays showed that two-thirds of the Pol-III activity is in
the cytoplasm, whereas only 16% and 11% of the Pol-I and
Pol-II activities are in the cytoplasm, respectively (Jaehning
and Roeder, 1977). These pioneering studies divided Pol-III
into two chromatographic forms (IIIA and IIIB). Only Pol-IIIA is
present in the nucleus, while approximately equal amounts of
Pol-IIIA and Pol-IIIB are found in the cytoplasm. It has been
a long-standing mystery why the majority of Pol-III activity is
present in the cytosol, where DNA should be avoided. OurFigure 6. Pol-III Is Required for the Production of IFN-Inducing RNA
(A) HeLa S100was immunodepleted five timeswith a POLR3F antibody or control IgG. S100 and the immunodepleted supernatants were incubated with poly(dA-
dT), UTP, and ATP before RNA was extracted for IFN-b reporter assays (upper panel). The efficiency of immunodepletion was analyzed by immunoblotting with
the POLR3F antibody (lower panel).
(B) HEK293 cells were transfected with or without poly(dA-dT) for 4 hr. Nuclear and cytosolic lysates were prepared for RNA extraction. HEK293-IFNb-luciferase
reporter cells were transfected with 0.5 mg or 15% of nuclear or cytosolic RNAs, followed by measurement of IFN-b induction.
(C) Two siRNA oligos against POLR3F (a and b) or a control GFP siRNAwere transfected into HEK293 cells. The cells were subsequently transfected with poly(dA-
dT) or infected with Sendai virus for 2 hr before RNAs were extracted for IFN-b reporter assays.
(D) HEK293/RIG-I-FLAG stable cells were transfected with siRNA as described in (C) and then transfectedwith poly(dA-dT) for 3 hr. The RIG-I complex was immu-
noprecipitated with a FLAG antibody, and then the RNAs associated with RIG-I were extracted and analyzed by northern blotting with a-32P-poly(A-U) RNA used
as a probe. RIG-I in the immunoprecipitates and POLR3F in cell lysates were analyzed by immunoblotting.
(E) HEK293 cells were treated with the indicated concentrations of the Pol-III inhibitor ML-60218 for 10 hr before transfection with poly(dA-dT) or infection with
Sendai virus for 2 hr. RNAs were extracted for IFN-b reporter assays.
(F) HEK293/RIG-I-FLAG stable cells were treated with ML-60218 and then transfected with poly(dA-dT). RNAs associated with the RIG-I complex were analyzed
by northern blotting as described in (D).
Error bars represent the variation range of duplicate experiments.Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc. 587
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finding that cytosolic Pol-III is a DNA sensor that mediates innate
immune response provides a potential answer to this conun-
drum. The cytosol is a strategic location for Pol-III to function
in immune defense, because RNA synthesized in the cytosol
contains 50-triphosphate that can be detected by RIG-I, whereas
RNA synthesized in the nucleus is likely to be modified by
enzymes such as the capping enzymes (e.g., mRNA) or pro-
cessed to generate 50-monophosphate (e.g., tRNA), which
escapes detection by RIG-I. Therefore, we propose that nuclear
and cytoplasmic RNA polymerases serve opposing functions:
while the nuclear polymerases produce the host RNA that should
be modified to avoid triggering autoimmune response through
the RIG-I pathway, the cytosolic Pol-III is specialized to detect
foreign and aberrant DNA to mount an immune response to
defend the integrity of the host cytoplasm.
Recognition of AT-Rich DNA Sequences by RNA Pol-III
At least three different complexes have been identified as tran-
scription factors for polymerase III (TFIIIA, TFIIIB, and TFIIIC)
(Schramm and Hernandez, 2002). TBP is one of the subunits in
TFIIIB, and it binds to the TATA box. The nature of the poly(dA-
dT) sequence might provide the TATA motifs for TBP binding.
However, TBP is not present in the highly purified Pol-III complex
that catalyzes in vitro transcription of poly(dA-dT), and TBP
immunoprecipitated from cytosolic extracts does not have the
transcription activity (Figures 4C and 4E). Therefore, TBP may
not be responsible for the preferential recognition of dA-dT-
rich sequences by Pol-III, although our results cannot rule out
the possibility that TBPmight play a role in DNA sequence recog-
nition by cytosolic Pol-III in vivo. The Pol-III complex we purified
contains at least 13 subunits; some of these subunits may deter-
mine the optimal sequences that permit transcription by Pol-III.
A recent study suggests that homopolymeric ribonucleotide
composition, such as A-U rich sequence, is required for RNA
to bind and activate RIG-I (Saito et al., 2008). Thus, it is possible
that a GC-rich DNA could still be transcribed into an RNA, but the
RNA lacks the ability to activate RIG-I. However, we found that
Pol-III could not transcribe poly(dG-dC) or poly(dG-dC-dA-dT)
DNA (Figure 5). Moreover, if we used T7 RNA polymerase to tran-
scribe an RNA containing a GCAU sequence or a randomsequence with 50% GC composition, this RNA could efficiently
induce IFN-b (Figure S9), indicating that the failure of GC-rich
DNA to induce IFN-b was due to the lack of the production of
the RNA rather than the inability of the GC-rich RNA to induce
IFN-b.
Detection of Viral and Bacterial DNA by Cytosolic RNA
Pol-III
Although many DNA viruses encode DNA-dependent RNA poly-
merases and some use the cellular RNA polymerases for viral
gene transcription, the majority of the viral RNA is modified by
cellular and virus-encoded modification enzymes such as the
capping enzymes. However, some viral RNAs, such as the
VA-I and VA-II RNAs from adenovirus and EBER1 and EBER2
RNAs from EBV, are noncoding small RNAs containing 50-
triphosphate (Lerner et al., 1981; Rosa et al., 1981). Our results
and those of previous studies suggest that these viral RNAs
are transcribed by cellular Pol-III. EBER genes contain internal
control sequence motifs (box A and B) that are recognized by
TFIIIB and TFIIIC, which direct Pol-III transcription (Schramm
and Hernandez, 2002). In addition, the upstream promoters of
EBER genes contain a TATA-like sequence that specifies Pol-III,
but not Pol-II, transcription (Howe andShu, 1993). Thus, the tran-
scription of cytosolic DNA, some of which is derived from
bacteria and viruses, is controlled not only by recognition of
dA-dT rich sequence by Pol-III, but also by other transcription
factors associated with Pol-III, such as TFIIIA, TFIIIB, and TFIIIC.
While the VA and EBER small RNAs are abundant Pol-III
transcripts that contain 50-triphosphate, they are normally in
complex with cellular proteins to form RNP particles that
predominantly reside in the nucleus (Lerner et al., 1981). There-
fore, these viral RNAs are segregated from RIG-I in the cytosol,
providing an explanation for why cells containing these abundant
viral RNAs do not produce copious amounts of IFN. This may be
a mechanism by which the virus evades the host immune
system, and it may also be a mechanism by which the host
avoids excessive autoimmune responses. However, the VA
and EBER RNP particles react with antibodies from SLE patients
(Lerner et al., 1981; Rosa et al., 1981). Both the sera from SLE
patients and cells chronically infected with EBV have elevatedFigure 7. Pol-III Is Required for IFN-b Induction by Intracellular Bacteria and DNA Viruses
(A) Wild-type or MAVS-deficient BMDM cells were infected with Legionella pneumophila for 8 hr. Total RNAs were extracted for qPCR. The expression level of
IFN-b was normalized with that of b-actin.
(B) Raw264.7 cells were treated with the indicated concentrations of ML-60218 for 10 hr and then infected with L. pneumophila. Total RNAs were extracted after
8 hr of infection for qPCR of IFN-b and b-actin.
(C) RNAs extracted from ML-60218-treated and L. pneumophila-infected Raw264.7 cells as described in (B) were transfected into Raw264.7 cells to induce
IFN-b.
(D) Raw264.7 cells were infected with L. pneumophila for 8 hr before nuclear and cytosolic lysates were prepared to extract RNAs. The RNAs were transfected
into Raw264.7 cells to induce IFN-b.
(E) Raw264.7 cells were treated with ML-60218 for 10 hr and infected with L. pneumophila for 24 hr. The bacterial colonies were counted and shown as CFU per
1000 cells.
(F) Raw264.7 cells were treated with ML-60218 in the presence or absence of mouse IFN-b and subsequently infected with L. pneumophila. Bacterial colonies
were determined as described in (E).
(G–I) Raw264.7 cells were treated with ML-60218 for 10 hr and then infected with adenovirus (AdV; G), Herpes Simplex Virus-1 (HSV-1; H) or Sendai virus (SeV; I).
Total RNAs were extracted for qPCR of IFN-b and b-actin.
(J) The Epstein-Bar virus (EBV)-producing B95-8 cells were treated with ML-60218 for 24 hr, and then total RNAs were prepared for qPCR. The expression levels
of EBER1, EBER2, IFN-b, and a-actin genes were normalized with that of the b-actin RNA.
Error bars represent standard deviations of triplicate experiments.Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc. 589
levels of type I interferons, and epidemiology studies have sug-
gested a link between EBV infection and SLE (Ronnblom and
Pascual, 2008). It is possible that under certain pathological
conditions, some of the viral RNA gains access to RIG-I, trig-
gering IFN production that contributes to autoimmune diseases.
Like viruses, intracellular bacteria are potent inducers of type I
interferons. However, the mechanisms by which bacteria induce
interferons are largely unknown. Interestingly, Mavs-deficient
macrophages are severely defective in producing IFN-b in
response to infection by Legionella pneumophila. Our finding
that Pol-III is required for IFN-b induction by L. pneumophila
provides a mechanism for the Mavs-dependent innate immune
response against this bacterium. Our results suggest that Pol-III
detects some segments of the bacterial DNA and transcribes
them into RNA ligands that induce IFN-b through the RIG-I-
MAVS pathway. The utilization of Pol-III as a DNA sensor for
bacteria and DNA viruses may allow the host to take advantage
of the RIG-I-MAVS pathway to defend against a much larger
spectrum of microbial pathogens.
MAVS-Dependent and -Independent Pathways
Triggered by Cytosolic DNA
Our results that deletion of MAVS or inhibition of Pol-III blocked
IFN-b production in response to Legionella infection suggest that
the Pol-III-MAVS pathway is the major pathway responsible for
interferon induction by this bacterium (Figures 7A and 7B).
Future research should reveal whether the MAVS-dependent
DNA-sensing pathway is the major pathway for immune defense
against other pathogens, including bacteria, DNA viruses, or
even parasites such as malaria. However, the Pol-III-MAVS
pathway is unlikely to be the only cytosolic DNA-sensing
pathway that induces type I IFNs. While the human cell lines
HEK293 and HeLa solely rely on the Pol-III-MAVS pathway to
induce IFN in response to poly(dA-dT), primary MEF cells
possess both MAVS-dependent and -independent pathways
to detect cytosolic DNA. Interestingly, we noticed that sponta-
neous immortalization of MEF cells by repeated passages led
to a loss of the MAVS-independent pathway (Y.C. and Z.J.C.,
unpublished data). It is not clear why immortalized or trans-
formed cells lose the MAVS-independent pathway, but it is inter-
esting to note that the loss of IFN induction by DNA transfection
in some transformed cells such as HEK293 and HeLa may allow
the widespread use of these cells in molecular cell biology. The
MAVS-independent pathway appears to recognize DNA struc-
ture rather than its sequence. Although the DNA-binding protein
DAI (ZBP1) has been proposed as a DNA sensor that induces
type I IFNs, DAI-deficient mice and cells from these mice do
not have apparent defects in producing type I IFNs in response
to DNA stimulation (Ishii et al., 2008; Takaoka et al., 2007). The
recently discovered DNA-binding protein AIM2 is clearly a cyto-
solic DNA sensor that activates the inflammasome and caspase-
1, but it does not induce type I IFNs (Schroder et al., 2009). It is
possible that multiple sensors exist to detect the invasion of
cytosol by foreign or aberrant self DNA. The identification of
these DNA sensors, including Pol-III, should provide critical
insights into themechanism of innate immune responses against
a large variety of microbial pathogens including bacteria and
viruses. Furthermore, this line of research will lead to a deeper590 Cell 138, 576–591, August 7, 2009 ª2009 Elsevier Inc.understanding of the mechanism underlying debilitating auto-
immune diseases such as lupus.
EXPERIMENTAL PROCEDURES
Nucleic Acid Extraction
Total RNAs were extracted by TRIzol (Invitrogen) from cells according to the
manufacturer’s instructions. For preparation of nuclear and cytoplasmic
RNA, cells were lysed in buffer A (10 mM HEPES [pH 7.5], 10 mM KCl, and
1.5 mM MgCl2) by douncing and centrifuged at 100 3 g for 5 min to remove
cell debris. The supernatant was centrifuged at 500 3 g for 5 min to collect
the nuclear pellet. The supernatant was further centrifuged at 20,000 3 g for
10 min to collect the cytosolic supernatant. Nucleic acids were extracted
from the nuclear and cytosolic lysates with phenol and chloroform, followed
by isopropanol precipitation.
In Vitro Reconstitution Assay
Cell extracts (S100) were prepared as described previously (Deng et al., 2000).
S100 (2 mg/ml) was incubated with poly(dA-dT) or poly(dG-dC) (20 mg/ml)
together with ATP (2 mM), MgCl2 (5 mM), and RNase inhibitor (0.4U/ml, Invitro-
gen) in a 50 ml reaction mixture at 30C for 1 hr. After incubation, 50 ml of buffer
A was added, and then nucleic acids were extracted by phenol/chloroform,
followed by isopropanol precipitation and DNase I digestion. The extracted
RNA was tested for IFN-b induction. For reconstitution experiments, dialyzed
proteins from ammonium sulfate precipitation or column fractions and heat
supernatant (heat sup) were used in the reactions in lieu of S100. Heat sup
was obtained by incubating HeLa S100 at 75C for 15 min followed by centri-
fugation at 20,000 3 g to collect the supernatant. For purification of small
molecules from the heat sup, the reaction mixtures contain 40% dialyzed
ammonium sulfate precipitates from S100, column fractions from heat sup,
poly(dA-dT), ATP, MgCl2, and RNase inhibitor. For purification of Pol-III,
the reaction mixtures contain column fractions from S100, UTP (0.2 mM),
poly(dA-dT), ATP, MgCl2, and RNase inhibitor.
Purification of the Enzyme that Converts DNA into IFN-Inducing RNA
HeLa S100 (440 mg) was applied to a HiTrap Q column (10 ml bed volume, GE
Healthcare) pre-equilibrated with buffer B (10mMHEPES [pH 8.0], 10mMKCl,
and 1.5 mM MgCl2), and eluted with a 100 ml linear gradient KCl (0–500 mM).
Fractions (380–500 mM) were dialyzed against buffer C (10 mM HEPES
[pH 8.0], 1 M (NH4)2SO4, 10 mM KCl, and 1.5 mM MgCl2) and loaded onto
a hydrophobic interaction chromatography (HIC) column (Phenyl-Sepharose
High Performance, 1 ml bed volume, GE Healthcare) pre-equilibrated with
buffer C. Bound proteins were eluted with a 10 ml linear reverse gradient of
(NH4)2SO4 (1.0–0 M). The active fractions (700–300 mM) were applied to
a Superose-6 gel filtration column (24 ml bed volume, GE Healthcare) pre-
equilibrated with buffer D (10 mM HEPES [pH 6.5], 10 mM KCl, 1.5 mM
MgCl2, and 0.02% CHAPS). After elution with buffer D, fractions containing
the activity were pooled and loaded onto a SP cation exchange column
(1 ml bed volume, GE Healthcare) pre-equilibrated with buffer D. Bound
proteins were eluted with a 10 ml linear gradient of KCl (0–500 mM). The active
fractions (100–250 mM KCl) were dialyzed against buffer E (10 mM HEPES
[pH 8.0], 10 mM KCl, 1.5 mM MgCl2, and 0.02% CHAPS) and applied to
a Heparin column with chicken ovalbumin (10 mg) as a carrier protein (1 ml
bed volume, GEHealthcare) pre-equilibrated with buffer E. The active fractions
(300–450 mM KCl) were eluted with a 10 ml linear gradient of KCl (0–500 mM)
and loaded onto a Superdex-200 gel filtration column (0.1 ml bed volume). The
SMART system was used for this and subsequent steps of purification, and
ovalbumin was used as a carrier. After elution with buffer E, the fractions
were applied to a Blue-Sepharose column (0.1ml bed volume, GEHealthcare).
The column was washed with 1M KCl, and the fraction containing the activity
was eluted with 2 M KCl. This fraction was further separated on a Superdex-
200 gel filtration column (0.1 ml bed volume). The fractions corresponding to
the peak of the activity were analyzed by 12% SDS-PAGE and silver staining.
The bands that copurified with the activity were excised for in-gel digestion
with trypsin and identified by nano-high-pressure liquid chromatography/
tandem mass spectrometry.
Viral and Bacterial Infection
Raw264.7 cells were pretreated with the Pol-III inhibitor, ML-60218 (Calbio-
chem), for 10 hr and then infected with an engineered adenovirus type 5
(Ad-CMV-GFP from Vector Biolabs; this virus lacks the E1 and E3 genes) at
100 multiplicity of infection (MOI), HSV-1 at 100 MOI, or Legionella pneumo-
phila (serogroup 1 strain AA100, from ATCC) at 50 MOI for 8 hr. Cells were
rinsed with PBS and lysed in Trizol for total RNA extraction.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, nine
figures, and one table and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)00714-4.
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